Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting Gys1 with AAV‐SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models

1 Apr 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Neurological Disorders and Treatments
Share to Genetics and Neurodevelopmental Disorders
Share to Glycogen Storage Diseases and Myoclonus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33830476
DOI: 10.1007/s13311-021-01040-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting Gys1 with AAV‐SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse ModelsPMID 33830476Read ↗

Targeting <i>Gys1</i> with AAV‐SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in Adult Polyglucosan Body and Lafora disease mouse modelsSemantic proximity Read ↗

Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches.Semantic proximity Read ↗

<i>Gys1</i> antisense therapy rescues neuropathological bases of murine Lafora diseaseSemantic proximity Read ↗

Disease mutation in gigaxonin-E3 ligase recapitulates giant axonal neuropathy in mice.Semantic proximity Read ↗

Therapeutic targeting the cGAS−STING pathway associated with protein and gene: An emerging and promising novel strategy for aging-related neurodegenerative diseaseSemantic proximity Read ↗

An Engineered sgsh Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA.Semantic proximity Read ↗

Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disordersSemantic proximity Read ↗

Animal Models of Polyglutamine Diseases and Therapeutic ApproachesSemantic proximity Read ↗

Patient-Specific Midbrain Organoids with CRISPR Correction Recapitulate Neuronopathic Gaucher Disease Phenotypes and Enable Evaluation of Novel TherapiesSemantic proximity Read ↗

Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency.Semantic proximity Read ↗

Perspectives in the investigation of Cockayne syndrome group B neurological disease: the utility of patient-derived brain organoid models.Semantic proximity Read ↗

Insights into Dentatorubral-Pallidoluysian Atrophy from a new <i>Drosophila</i> model of diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.